Reduced mechanical function of the left atrial predicts adverse outcome in pregnant women with clustering of metabolic risk factors

Table 4 Clinical and echocardiographic parameters of pregnant women with metabolic diseases comparing with and without adverse outcome (N = 177)

Variables	Women with adverse outcome (n = 42)	Women without adverse outcome (n = 135)	P value
Age, years	32.02 ± 3.76	31.91 ± 3.99	0.871
BSA, m²	1.81 ± 0.15	1.81 ± 0.13	1.000
Pre-BMI, Kg/m²	25.43 ± 4.19	23.38 ± 3.49	0.002
TG, mmol/L	4.21 ± 1.41	3.83 ± 1.72	0.185
HDL-C, mmol/L	1.57 ± 0.41	1.85 ± 0.46	< 0.001
SBP, mmHg	152.09 ± 13.71	138.00 ± 18.28	< 0.001
DBP, mmHg	96.26 ± 10.24	84.59 ± 11.53	< 0.001
FPG, mmol/L	4.61 ± 0.83	4.87 ± 0.84	0.079
LV EF, %	62.46 ± 3.38	63.50 ± 4.16	0.143
LV E/e’	9.46 ± 2.19	8.41 ± 2.70	0.012
LV GLS (%)	20.36 ± 2.14	21.31 ± 2.31	0.019
LAVi, ml/m²	24.87 ± 6.82	22.36 ± 4.94	0.032
LA EF, %	37.69 ± 9.79	40.15 ± 9.35	0.145
LASr (%)	36.05 ± 4.77	41.84 ± 5.97	< 0.001

Values are the mean ± standard deviation
BSA, Body Surface Area; pre-BMI, pre-pregnancy body mass index; TG, triglyceride; HDL-C, high-density lipoproteins-cholesterol; SBP, systolic blood pressure; DBP, systolic blood pressure;FPG, fasting plasma glucose; LV EF, left ventricular ejection fraction; LV E/e’, ratio of early diastolic mitral flow velocity to early diastolic peak velocity of lateral mitral annulus; LV GLS, left ventricular global longitudinal strain; LAVi, left atrial volume index; LA EF, left atrial ejection fraction; LASr, left atrial strain during reservoir phase;

ISSN: 1471-2261